News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
720,994 Results
Type
Article (42687)
Company Profile (439)
Press Release (677867)
Multimedia
Podcasts (91)
Webinars (16)
Section
Business (208881)
Career Advice (2025)
Deals (36047)
Drug Delivery (104)
Drug Development (83692)
Employer Resources (173)
FDA (16509)
Job Trends (15130)
News (353170)
Policy (33154)
Tag
Academia (2645)
Accelerated approval (12)
Adcomms (26)
Allergies (98)
Alliances (51105)
ALS (114)
Alzheimer's disease (1500)
Antibody-drug conjugate (ADC) (167)
Approvals (16491)
Artificial intelligence (331)
Autoimmune disease (33)
Automation (19)
Bankruptcy (373)
Best Places to Work (11841)
BIOSECURE Act (19)
Biosimilars (123)
Biotechnology (331)
Bladder cancer (98)
Brain cancer (36)
Breast cancer (375)
Cancer (2956)
Cardiovascular disease (227)
Career advice (1695)
Career pathing (30)
CAR-T (194)
CDC (32)
Cell therapy (527)
Cervical cancer (22)
Clinical research (68684)
Collaboration (1067)
Company closure (3)
Compensation (699)
Complete response letters (28)
COVID-19 (2684)
CRISPR (64)
C-suite (342)
Cystic fibrosis (118)
Data (3053)
Decentralized trials (2)
Denatured (31)
Depression (71)
Diabetes (351)
Diagnostics (6484)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (147)
Drug pricing (130)
Drug shortages (29)
Duchenne muscular dystrophy (133)
Earnings (88710)
Editorial (44)
Employer branding (21)
Employer resources (149)
Events (117370)
Executive appointments (873)
FDA (18187)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (976)
Gene editing (141)
Generative AI (23)
Gene therapy (406)
GLP-1 (826)
Government (4593)
Grass and pollen (4)
Guidances (181)
Healthcare (19172)
HIV (42)
Huntington's disease (31)
IgA nephropathy (43)
Immunology and inflammation (164)
Immuno-oncology (8)
Indications (40)
Infectious disease (2860)
Inflammatory bowel disease (156)
Inflation Reduction Act (13)
Influenza (64)
Intellectual property (122)
Interviews (312)
IPO (16875)
IRA (47)
Job creations (3708)
Job search strategy (1436)
Kidney cancer (13)
Labor market (52)
Layoffs (525)
Leadership (20)
Legal (8006)
Liver cancer (80)
Longevity (11)
Lung cancer (414)
Lymphoma (212)
Machine learning (11)
Management (58)
Manufacturing (399)
MASH (94)
Medical device (13613)
Medtech (13618)
Mergers & acquisitions (19892)
Metabolic disorders (887)
Multiple sclerosis (99)
NASH (19)
Neurodegenerative disease (129)
Neuropsychiatric disorders (39)
Neuroscience (2217)
NextGen: Class of 2025 (6759)
Non-profit (4558)
Now hiring (47)
Obesity (452)
Opinion (237)
Ovarian cancer (103)
Pain (112)
Pancreatic cancer (121)
Parkinson's disease (193)
Partnered (22)
Patents (303)
Patient recruitment (170)
Peanut (51)
People (59094)
Pharmaceutical (86)
Pharmacy benefit managers (22)
Phase I (21588)
Phase II (30311)
Phase III (22388)
Pipeline (1665)
Policy (212)
Postmarket research (2601)
Preclinical (9274)
Press Release (67)
Prostate cancer (146)
Psychedelics (44)
Radiopharmaceuticals (272)
Rare diseases (490)
Real estate (6025)
Recruiting (67)
Regulatory (23117)
Reports (50)
Research institute (2422)
Resumes & cover letters (352)
Rett syndrome (9)
RNA editing (10)
RSV (49)
Schizophrenia (94)
Series A (169)
Series B (116)
Service/supplier (11)
Sickle cell disease (66)
Special edition (21)
Spinal muscular atrophy (153)
Sponsored (33)
Startups (3776)
State (2)
Stomach cancer (15)
Supply chain (77)
Tariffs (57)
The Weekly (58)
Vaccines (801)
Venture capital (56)
Weight loss (278)
Women's health (49)
Worklife (17)
Date
Today (95)
Last 7 days (367)
Last 30 days (1939)
Last 365 days (32088)
2025 (17275)
2024 (36302)
2023 (41015)
2022 (52276)
2021 (56763)
2020 (54920)
2019 (47416)
2018 (35696)
2017 (33024)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (738)
Alabama (67)
Alaska (7)
Arizona (252)
Arkansas (14)
Asia (39655)
Australia (6580)
California (7601)
Canada (2378)
China (695)
Colorado (328)
Connecticut (333)
Delaware (195)
Europe (86724)
Florida (1125)
Georgia (249)
Hawaii (1)
Idaho (59)
Illinois (659)
India (27)
Indiana (365)
Iowa (18)
Japan (232)
Kansas (112)
Kentucky (30)
Louisiana (15)
Maine (64)
Maryland (1045)
Massachusetts (5747)
Michigan (248)
Minnesota (458)
Mississippi (3)
Missouri (91)
Montana (30)
Nebraska (25)
Nevada (81)
New Hampshire (70)
New Jersey (2123)
New Mexico (30)
New York (2118)
North Carolina (1150)
North Dakota (9)
Northern California (3319)
Ohio (239)
Oklahoma (16)
Oregon (38)
Pennsylvania (1631)
Puerto Rico (17)
Rhode Island (37)
South America (1112)
South Carolina (34)
South Dakota (1)
Southern California (2833)
Tennessee (126)
Texas (1148)
United States (28280)
Utah (223)
Virginia (191)
Washington D.C. (74)
Washington State (658)
West Virginia (4)
Wisconsin (70)
720,994 Results for "arcturus therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Arcturus Prunes Early-Stage Pipeline, Leans Into mRNA Therapies
Arcturus is extending its cash runway into 2028 by discontinuing its early-stage vaccine candidates.
May 14, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Arcturus Therapeutics to Attend Upcoming June 2025 Investor Conferences
May 30, 2025
·
1 min read
Press Releases
Arcturus Therapeutics Announces Positive Interim Phase 2 Multiple Dose Data for Ornithine Transcarbamylase (OTC) Deficiency Program
June 30, 2025
·
12 min read
Press Releases
Arcturus Therapeutics Announces First Quarter 2025 Financial Update and Pipeline Progress
May 12, 2025
·
12 min read
Press Releases
Arcturus Therapeutics to Host Key Opinion Leader (KOL) Presentation of ARCT-810 Phase 2 Interim Data for Ornithine Transcarbamylase (OTC) Deficiency
June 23, 2025
·
8 min read
Press Releases
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 12, 2025
April 23, 2025
·
1 min read
Press Releases
Arcturus Therapeutics to Present at Leerink’s Global Healthcare Conference 2025
March 5, 2025
·
1 min read
Press Releases
Messenger RNA Market Research Report 2025-2035, Competitive Analysis of Pfizer, GSK, Arcturus Therapeutics, AstraZeneca, Beam Therapeutics, Moderna, Oncotelic, SK Bioscience, Sangamo, Sanofi CureVac
June 11, 2025
·
6 min read
Business
Arcturus Therapeutics Appoints Moncef Slaoui, Ph.D., to Board of Directors
Arcturus Therapeutics Holdings Inc. today announced the appointment of a new independent director, Moncef Slaoui, Ph.D., to the Company’s Board of Directors.
June 20, 2024
·
5 min read
Biotech Beach
Arcturus Therapeutics Announces Positive Development for Cystic Fibrosis Program
Arcturus Therapeutics Holdings Inc. announced Arcturus will be presenting Phase 1 results in healthy volunteers and new Phase 1b interim data in CF patients for ARCT-032, an inhaled investigational mRNA therapeutic to treat CF, at the 47th European Cystic Fibrosis Conference on June 7, 2024.
May 28, 2024
·
5 min read
1 of 72,100
Next